Royalty Pharma
RPRX
#622
Rank
ยฃ30.07 B
Marketcap
ยฃ52.30
Share price
-0.01%
Change (1 day)
74.27%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): ยฃ1.15

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is ยฃ1.16. In 2025 the company made an earnings per share (EPS) of ยฃ1.36 a decrease over its 2024 EPS that were of ยฃ1.47.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ1.15-15.76%
2025ยฃ1.36-7.1%
2024ยฃ1.47
2020ยฃ1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
ยฃ2.06 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.53 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ3.95 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA